RNA Details
                    Disease Name
                    
                    pulmonary hypertension
                    
                    Tissue
                    
                    lung
                    
                    RNA Symbol
                    
                    Nox4
                    
                RNA ID
                    
                    
                    
                RNA Type
                    
                    mRNA
                    
                Alteration Pattern
                    
                    histone deacetylation
                    
                Species
                    
                    rattus norvegicus
                    
                Detection Methods
                    
                    Engineered CRISPR-Cas9 and DNA constructs; qRT-PCR; Promoter activity assays etc.
                    
                Target
                    
                    NA
                    
                Pathway
                    
                    NA
                    
                PubMed ID
                    
                    
                    
                    
                    
                Title
                    
                    Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension
                    
                Year
                    
                     2016
                    
                Function
                    
                    "HDAC inhibitors block the binding of RNA polymerase II and the histone acetyltransferase p300 to the Nox2, Nox4 and Nox5 promoter regions and decrease histones activation marks (H3K4me3 and H3K9ac) at these promoter sites. In a monocrotaline (MCT) rat model of PAH, multiple HDAC isoforms are upregulated in isolated pulmonary arteries, and HDAC inhibitors attenuate Nox expression in isolated pulmonary arteries and reduce indices of PAH. In conclusion, HDAC inhibitors potently suppress Nox gene expression both in vitro and in vivo via epigenetically regulating chromatin accessibility."